Skip to main content
In stock|Targeted Therapy

ARV-471 (Vepdegestrant)

Oncology TypeSolid Tumour (Prostate)
Drug Class / MechanismAndrogen Receptor Degrader (PROTAC)
No Image
Description

ARV-471 (Vepdegestrant) is classified as an Androgen Receptor Degrader (PROTAC), sourced for use within our Targeted Therapy portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic CategoryTargeted Therapy
Oncology TypeSolid Tumour (Prostate)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3